Correlation Between DBV Technologies and Zealand Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DBV Technologies and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DBV Technologies and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DBV Technologies and Zealand Pharma AS, you can compare the effects of market volatilities on DBV Technologies and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DBV Technologies with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of DBV Technologies and Zealand Pharma.

Diversification Opportunities for DBV Technologies and Zealand Pharma

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between DBV and Zealand is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding DBV Technologies and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and DBV Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DBV Technologies are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of DBV Technologies i.e., DBV Technologies and Zealand Pharma go up and down completely randomly.

Pair Corralation between DBV Technologies and Zealand Pharma

Given the investment horizon of 90 days DBV Technologies is expected to under-perform the Zealand Pharma. In addition to that, DBV Technologies is 1.6 times more volatile than Zealand Pharma AS. It trades about -0.03 of its total potential returns per unit of risk. Zealand Pharma AS is currently generating about 0.05 per unit of volatility. If you would invest  9,106  in Zealand Pharma AS on September 2, 2024 and sell it today you would earn a total of  1,299  from holding Zealand Pharma AS or generate 14.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.21%
ValuesDaily Returns

DBV Technologies  vs.  Zealand Pharma AS

 Performance 
       Timeline  
DBV Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DBV Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, DBV Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Zealand Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

DBV Technologies and Zealand Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DBV Technologies and Zealand Pharma

The main advantage of trading using opposite DBV Technologies and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DBV Technologies position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.
The idea behind DBV Technologies and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon